Ligand · MTI
MTI · 3,4-dihydroxy-2-[(methylsulfanyl)methyl]-5-(4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidinium
MTI, 3,4-dihydroxy-2-[(methylsulfanyl)methyl]-5-(4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidinium (C12 H17 N4 O3 S +1, 297.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site…
- Component
- MTI
- Formula
- C12 H17 N4 O3 S +1
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
MTI in 2 structures; the first of them:
- 1Q1G · Crystal structure of Plasmodium falciparum PNP with 5'-methylthio-immucillin-H · MTI A301 · binds VAL66, ARG88, SER91, CYS92, GLY93, TYR160, VAL181, GLU182 and 8 more
- 1Q1G · Crystal structure of plasmodium falciparum pnp with 5'-methylthio- immucillin-H · MTI A301 · binds VAL66, ARG88, SER91, CYS92, GLY93, TYR160, VAL181, GLU182 and 8 more
Residues it binds most
VAL 12, ARG 12, GLU 12, ASP 12, CYS 12, GLY 12, HIS 12, MET 12, PRO 12, SER 12 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.